J. Lipid Res. Please sign the JLR Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1194/jlr.M600312-JLR200 on September 13, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M600312-JLR200v1
47/12/2799    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brouwers, M. C. G. J.
Right arrow Articles by de Bruin, T. W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brouwers, M. C. G. J.
Right arrow Articles by de Bruin, T. W. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 47, 2799-2807, December 2006
Copyright © 2006 by American Society for Biochemistry and Molecular Biology


Patient-Oriented Research

Heritability and genetic loci of fatty liver in familial combined hyperlipidemia

Martijn C. G. J. Brouwers1,*, Rita M. Cantor{dagger},§, Naoko Kono{dagger}, Jeong lim Yoon{dagger}, Carla J. H. van der Kallen*, Monique A. L. Bilderbeek-Beckers**, Marleen M. J. van Greevenbroek*, Aldons J. Lusis{dagger},{dagger}{dagger} and Tjerk W. A. de Bruin*,2

* Department of Medicine and Cardiovascular Research Institute Maastricht, Academic Hospital Maastricht, Maastricht, The Netherlands
{dagger} Department of Human Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA
§ Department of Pediatrics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA
** Department of Radiology, VieCuri Medical Center Noord Limburg, Venlo, The Netherlands
{dagger}{dagger} Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA

Published, JLR Papers in Press, September 13, 2006.

2 Present address of T. W. A. de Bruin: GlaxoSmithKline, Translational Medicine and Genetics, Research Triangle Park, NC 27713.

1 To whom correspondence should be addressed. e-mail: martijn.brouwers{at}intmed.unimaas.nl


ABSTRACT

VLDL overproduction, a process that is driven by an excess amount of hepatic fat, is a well-documented feature of familial combined hyperlipidemia (FCHL). The aims of this study were to investigate whether fatty liver, measured with ultrasound and as plasma alanine aminotransferase (ALT) levels, develops against a genetic background in FCHL and to identify chromosomal loci that are linked to these traits. In total, 157 FCHL family members and 20 spouses participated in this study. Radiological evidence of fatty liver was more prevalent not only in FCHL probands (40%) but also in their relatives (35%) compared with spouses (15%) (P < 0.05). Heritability calculations revealed that 20–36% of the variability in ALT levels could be attributed to genetic factors. Nonparametric quantitative trait locus (QTL) analysis revealed three significant (P < 0.001) loci with either the ultrasound or the ALT trait in the male sample: 1q42.3, 7p12-21, and 22p13-q11; none was found in the female sample or the entire group. Of these QTLs, the 7p region was consistent over time, because reanalysis with ALT levels that were determined during a visit 5 years earlier yielded similar results. This study shows that fatty liver is a heritable aspect of FCHL. Replication of particularly the 7p region is awaited.

Supplementary key words steatosis • nonalcoholic fatty liver disease • quantitative trait locus • linkage analysis • alanine aminotransferase


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Lusis and R. A. Mar-Heyming
Caution on the Interpretation of Plasma Fatty Acid Composition as a Proxy Marker for SCD1 Activity: Particular Implications for Using the 16:1/16:0 Ratio in QTL Studies Involving Hyperlipidemic Patients
Arterioscler. Thromb. Vasc. Biol., August 1, 2008; 28(8): e153 - e153.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.